Ignite Creation Date:
2025-12-24 @ 10:42 PM
Ignite Modification Date:
2026-01-05 @ 6:27 PM
Study NCT ID:
NCT03818035
Status:
COMPLETED
Last Update Posted:
2025-04-27
First Post:
2019-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis
Sponsor:
Janssen-Cilag International NV
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2019-01-11
First Submit QC Date:
None
Study First Post Date:
2019-01-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-03-06
Results First Submit QC Date:
None
Results First Post Date:
2023-05-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-24
Last Update Post Date:
2025-04-27
Last Update Post Date Type:
ACTUAL